Medplus Health Services is currently trading at Rs. 810.00, up by 2.00 points or 0.25% from its previous closing of Rs. 808.00 on the BSE.
The scrip opened at Rs. 815.00 and has touched a high and low of Rs. 818.15 and Rs. 810.00 respectively. So far 620 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 2 has touched a 52 week high of Rs. 864.65 on 29-May-2023 and a 52 week low of Rs. 570.00 on 10-Nov-2022.
Last one week high and low of the scrip stood at Rs. 834.75 and Rs. 778.85 respectively. The current market cap of the company is Rs. 9639.90 crore.
The promoters holding in the company stood at 40.43%, while Institutions and Non-Institutions held 32.65% and 26.93% respectively.
MedPlus Health Services is planning to sell over 500 off-patent therapeutic and chronic medicines under its own brand with a massive discount of 50-80 per cent. The company tied up with multiple reputed pharmaceutical manufacturing companies to produce high quality off-patent medicines that enables the firm to pass on the benefit to the consumer.
The company will initially offer discounts on over 500 therapeutic and chronic medicines and will eventually extend discounts on more than 800 products in the next three months. These medicines will include over-the-counter (OTC) and prescription drugs used in treating various diseases such as hypertension, diabetes and kidney ailments.
MedPlus Health Services offers a wide range of products, including pharmaceutical and wellness products such as medicines, vitamins, medical devices and test kits, and FMCG products such as home and personal care products, including toiletries, baby care products, soaps and detergents and sanitizers